Stanford researchers have found a solution to enhance mRNA translation and stability by harnessing SARS-CoV2 genomic sequences themselves. They discovered that the SARS-CoV2 5' untranslated region (5' UTR) can be repurposed for increased translation and stability of any mRNA.
Stanford researchers have discovered that ribonucleoside vanadyl complexes can be used as an additive in transcription reactions resulting in ~2-fold increased yield.
Stanford researchers have developed one of the smallest, active translational enhancers that can be adapted to control gene regulation. The translation enhancer is a short RNA stem-loop structure isolated from a Hox gene.
Stanford researchers at the Bao Research Group have developed a second-generation stretchable multi-sensor tag technology for detecting physiological signals.
Heart rhythm disorders are difficult to treat with conventional drug therapy and intraoperative injury to the cardiac conduction system (CCS) complicates heart-related surgeries and is a major cause of morbidity and mortality.
A novel method for dissociating plant tissues for biochemical and genomic analysis that accommodates harsher digestion conditions with increased tissue dissociation efficiency and quality of isolated RNA.
Stanford researchers have formulated a risk scoring calculator using a human induced pluripotent stem cell (iPSC) model to accurately predict and calculate insulin resistance via a novel blood test.
Using a novel convolutional neural network architecture, PlexusNet can be used for histologic image analysis with smaller parameter and training sets than current state-of-the-art models.
Researchers at Stanford have discovered that treatment with JNK II inhibitor and IBMX has a synergistic therapeutic effect against osteoarthritis (OA).